title: Logical Analysis of Regulation of Interleukin-12 Expression Pathway Regulation During HCV Infection.
abstract: Hepatitis C virus (HCV) triggers coordinated innate and adaptive response in host cell. HCV genome and proteins of the replicating virus are recognized as non-self-antigens by host cell to activate Toll Like Receptors (TLRs). Activated TLRs ultimately express cytokines, which can clear virus either by activating interferon (IFN), protein kinase C (PKC) and RNA Lase system or through activation of cytotoxic T-lymphocytes. Interleukin-12 (IL-12) is a potent antiviral cytokine, capable of clearing HCV by bridging both innate and adaptive antiviral immune response. Activation of TLR-4 on macrophages surface induces expression of IL-12 via NF-κB and AP-1 transcriptional pathway. After expression, IL- 12 releases IFN-γ, which activates anti-HCV cytotoxic lymphocytes. Conversely, in chronic HCV infection downregulation of IL-12 has been reported instead of by number of studies. Keeping in view of the above mentioned facts, this study was designed to evaluate HCV-core mediated down-regulation of IL-12 transcriptional pathway by employing a logical modeling approach based on the Ren´e Thomas formalism. The logical parameters of entities were estimated by using SMBioNet. The Logical model represents all possible dynamics of protein expression involved during course of HCV pathology. Results demonstrated that at chronic stage of infection, though TLR-4 was constantly active but yet it failed to express the NF-κB, AP-1, IL-12 and IFN-γ. This mechanism was indicative of incorporation of core mediated changes in IL-12 regulatory pathway. Moreover, results also indicate that HCV adopts different trajectories to accomplish the persistence of chronic phase of infection. It also implicated that human immune system tries to clear HCV but core is capable of inducing system oscillations to evade the immunity.
authors.forename: Zia-Ur-Rehman
authors.initials: ZU
authors.lastname: Farooqi
authors.forename: Samar H K
authors.initials: SH
authors.lastname: Tareen
authors.forename: Jamil
authors.initials: J
authors.lastname: Ahmed
authors.affiliation: School of Applied Biosciences, National University of Sciences and Technology, Sector H-12, Islamabad, Pakistan. zaidi.sahar@gmail.com.
authors.forename: Najam-Us-Sahar S
authors.initials: NU
authors.lastname: Zaidi
mesh_terms: D005786:Gene Expression Regulation / Q000276:immunology; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000821:virology; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology*; D053765:Interleukin-12 Subunit p35 / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D016328:NF-kappa B / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D051197:Toll-Like Receptor 4 / Q000276:immunology*; D018808:Transcription Factor AP-1 / Q000378:metabolism
chemical_list: C508858:IL12A protein, human; D053765:Interleukin-12 Subunit p35; D016328:NF-kappa B; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D018808:Transcription Factor AP-1; D007371:Interferon-gamma